Pantoprazole Sodium

Treats Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD). Sold as Protonix, Protonix Iv, Pantoprazole Sodium, Pantoprazole Sodium In 0.9% Sodium Chloride. Every FDA application for this active ingredient: 6 branded and 42 generic.

As of Nov 15, 2026, FDA lists 48 applications for Pantoprazole Sodium (sold as Protonix, Protonix Iv, Pantoprazole Sodium and others), first approved Feb 2, 2000, with 6 new uses approved and 0 published complete response letters.

• First approved: Feb 2, 2000
• Applications: 48
• New uses approved: 6
• Complete response letters: 0
• Medicare spending, 2025: $339M
• First approved in the EU: Jun 11, 2009